Endothelial nitric oxide synthase (eNOS) is critical in the regulation of vascular function, and can generate both nitric oxide (NO) and superoxide (O 2 .2 ), which are key mediators of cellular signalling. In the presence of Ca 21 /calmodulin, eNOS produces NO, endothelialderived relaxing factor, from L-arginine (L-Arg) by means of electron transfer from NADPH through a flavin containing reductase domain to oxygen bound at the haem of an oxygenase domain, which also contains binding sites for tetrahydrobiopterin (BH 4 ) and L-Arg [1] [2] [3] . In the absence of BH 4 , NO synthesis is abrogated and instead O 2
/calmodulin, eNOS produces NO, endothelialderived relaxing factor, from L-arginine (L-Arg) by means of electron transfer from NADPH through a flavin containing reductase domain to oxygen bound at the haem of an oxygenase domain, which also contains binding sites for tetrahydrobiopterin (BH 4 ) and L-Arg [1] [2] [3] . In the absence of BH 4 , NO synthesis is abrogated and instead O 2
.2 is generated [4] [5] [6] [7] . While NOS dysfunction occurs in diseases with redox stress, BH 4 repletion only partly restores NOS activity and NOS-dependent vasodilation 7 . This suggests that there is an as yet unidentified redox-regulated mechanism controlling NOS function. Protein thiols can undergo S-glutathionylation, a reversible protein modification involved in cellular signalling and adaptation 8, 9 . Under oxidative stress, S-glutathionylation occurs through thiol-disulphide exchange with oxidized glutathione or reaction of oxidant-induced protein thiyl radicals with reduced glutathione 10, 11 . Cysteine residues are critical for the maintenance of eNOS function 12, 13 ; we therefore speculated that oxidative stress could alter eNOS activity through S-glutathionylation. Here we show that S-glutathionylation of eNOS reversibly decreases NOS activity with an increase in O 2
.2 generation primarily from the reductase, in which two highly conserved cysteine residues are identified as sites of S-glutathionylation and found to be critical for redox-regulation of eNOS function. We show that eNOS Sglutathionylation in endothelial cells, with loss of NO and gain of O 2
.2 generation, is associated with impaired endothelium-dependent vasodilation. In hypertensive vessels, eNOS S-glutathionylation is increased with impaired endothelium-dependent vasodilation that is restored by thiol-specific reducing agents, which reverse this S-glutathionylation. Thus, S-glutathionylation of eNOS is a pivotal switch providing redox regulation of cellular signalling, endothelial function and vascular tone.
We observed that oxidized glutathione (GSSG) induces dosedependent S-glutathionylation of human eNOS (heNOS) that was reversed by reducing agents, such as 2-mercaptoethanol or dithiothreitol (DTT) (Fig. 1a) . S-Glutathionylation greatly decreased NOS activity (Fig. 1b) in a dose-dependent manner ( Supplementary Fig. 1 ), but this was reversed by DTT with more than 80% recovery. When accessible thiols were alkylated by N-ethylmaleimide (NEM), NOS activity was abolished (more than 95% decrease; Fig. 1b ). As expected, the NOS activity of control, S-glutathionylated or S-alkylated heNOS was totally inhibited by the NOS inhibitor L-N G -nitroarginine methyl ester (L-NAME). In contrast to the marked (more than 70%) loss of NOS activity with S-glutathionylation, only a 56% decrease in NADPH consumption was seen that was only partly inhibited by L-NAME or the Ca 21 chelator EGTA ( Supplementary Fig. 2 ). Although thiol-alkylation abolished NOS activity, it decreased NADPH consumption by only about 50%, and this was not inhibited by L-NAME or EGTA. Thus, thiol modification uncouples eNOS with electron leakage from the reductase.
Because electron leakage could trigger O 2 .2 generation, electron paramagnetic resonance (EPR) spin trapping was performed to demonstrate a, Immunoblotting of heNOS S-glutathionylation. Top: immunoblotting of protein S-glutathionylation (PrS-SG) with anti-GSH antibody. Control non-Sglutathionylated heNOS (1 mg in 20 ml) or heNOS S-glutathionylated by 0.5, 1 or 2 mM GSSG at room temperature (23 uC) for 1 h. Treatment with 2-mercaptoethanol (ME) after S-glutathionylation with 2 mM GSSG reversed the S-glutathionylation. Bottom: immunoblotting with anti-eNOS antibody. b, Effect of S-glutathionylation and S-alkylation on heNOS activity. NOS activity was measured from control, S-glutathionylated (2 mM GSSG for 20 min) or alkylated (1 mM NEM for 20 min) heNOS. NOS activity of treated or untreated heNOS was fully inhibited by L-NAME (1 mM) or EGTA (1 mM -adduct signal that was quenched by Cu,Zn superoxide dismutase (Fig. 1c) . The NOS inhibitor L-NAME, which blocks O 2 .2 generation from the oxygenase, only partly blocked this O 2
.2 generation (Fig. 1d) , and it was also incompletely blocked by EGTA. S-Alkylation of heNOS increased O 2 .2 generation (about fourfold), and this was not blocked by L-NAME or EGTA. In contrast, the low-level O 2 .2 production from control heNOS was fully quenched by L-NAME or EGTA. Thus, S-glutathionylation and S-alkylation uncouple heNOS, greatly increasing O 2 .2 generation, and the partial or complete lack of inhibition by L-NAME suggests that the observed O 2 .2 is largely derived from the reductase domain.
To investigate the mechanism of S-glutathionylation-induced heNOS uncoupling, we sought to determine the specific residues modified. We therefore subjected S-glutathionylated heNOS to proteolytic digestion and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. Peptides with a mass difference of 305 Da, representing one glutathione moiety, were detected by LC-MS and their primary sequence was determined by MS/MS. We identified two glutathionylated cysteine residues within the reductase domain, namely Cys 689 and Cys 908, from both trypsin and chymotrypsin digestions ( Supplementary Fig. 3a, b) . Using molecular modelling to predict the three-dimensional structure of the heNOS reductase domain ( Supplementary Fig. 4 ), we found that Cys 689 and Cys 908 are located on the domain surface surrounded by several positively charged residues, and thus would probably be deprotonated at physiological pH, making them good candidates for S-glutathionylation.
S-Glutathionylation results in the formation of a mixed disulphide bond between the reactive Cys-thiol and reduced glutathione (GSH), a tripeptide consisting of glycine, cysteine and glutamate. The addition of this bulky negatively charged group can alter protein structure and function in a similar manner to the addition of a phosphate 14, 15 . Our molecular modelling reveals that both Cys 689 and Cys 908 are located at the interface of the FAD-binding and FMN-binding domains. Modification of these residues would therefore disrupt FAD-FMN alignment, interrupting electron transfer between the flavins and enhancing their solvent accessibility 16 ( Supplementary Fig. 4 
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Whereas wild-type (WT) heNOS is S-glutathionylated by GSSG with a roughly 70% loss of NOS activity, CysRSer mutants resist glutathionylation, with no loss of NOS activity in the double mutant and only modest loss in the single mutants ( Fig. 2a-c ). These mutants also resist GSSG-induced eNOS uncoupling with O 2 .2 generation. Thus, both Cys 689 and Cys 908 are critical for the redox regulation of eNOS.
Next we sought to determine the consequences of eNOS S-glutathionylation in endothelial cells. Inhibition of glutathione reductase by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) decreases the cellular GSH/GSSG ratio, leading to protein S-glutathionylation 17, 18 . Previous studies of bovine aortic endothelial cells (BAECs) treated with BCNU reported eNOS inhibition with glutaredoxin or thioredoxin inactivation 19, 20 ; however, the molecular mechanism of this process and alterations in eNOS were not investigated. In our current study of BAECs treated with BCNU, confocal microscopy demonstrated marked cellular S-glutathionylation that co-localized with eNOS (Fig. 3a , left columns). Immunoprecipitation of eNOS followed by immunoblotting confirmed that the BCNU-induced increase in GSSG led to eNOS S-glutathionylation (Fig. 3a, bottom) . This was further confirmed by mass spectrometry, in which Cys 689 was more than 50% Sglutathionylated ( Supplementary Fig. 5 ). BCNU-treated BAECs showed increased O 2 .2 generation that was blocked by DTT, which reversed the eNOS S-glutathionylation (Fig. 3a , right column, and Supplementary Fig. 6 ). BCNU also dose-dependently decreased cellular eNOS-derived NO production ( Supplementary Fig. 7 ). Thus, alterations in the cellular GSH/GSSG ratio led to the S-glutathionylation of eNOS, and this resulted in decreased NO Fig. 8 ).
To further determine whether redox stress leading to Sglutathionylation alters endothelial function in vessels, aortic segments were pre-exposed to BCNU and then measurements of endotheliumdependent or endothelium-independent relaxation were performed. In BCNU-exposed vessels, a marked decrease in endothelium-dependent vasodilation was seen (Fig. 4a, left panel) , whereas endotheliumindependent vasodilation elicited by exogenous NO was unaffected (Fig. 4a, right panel) . Furthermore, DTT, which reverses eNOS S-glutathionylation, restored endothelium-dependent vasodilation in BCNU-treated vessels.
Oxidant-stress-induced disruption of endothelium-dependent vasodilation is involved in the pathogenesis of hypertension, atherosclerosis and other cardiovascular disease 21 . Because eNOS S-glutathionylation profoundly impaired endothelium-dependent vasodilation, we speculated that there might be an increase in eNOS S-glutathionylation in hypertension. Indeed, in the vessels of spontaneously hypertensive (SHR) rats en face immunohistology showed marked S-glutathionylation with prominent endothelial co-localization with eNOS ( Supplementary Fig. 9 ), whereas control normotensive vessels (from WKY rats) had little S-glutathionylation. Immunoprecipitation of eNOS confirmed these results, showing much higher eNOS S-glutathionylation in vessels from SHR rats in comparison with vessels from WKY rats (Fig. 4c) . The marked decrease in endothelium-dependent vasodilation of aortic rings from SHR rats was reversed by thiol-specific reducing agents that concurrently reverse eNOS S-glutathionylation (Fig. 4b, c) . Thus, just as in the in vitro and ex vivo settings, eNOS S-glutathionylation occurs in vessels in vivo and increases with oxidative stress, resulting in a loss of endothelium-dependent relaxation, leading to hypertension. Other redox modifications of critical thiols on eNOS or other important regulatory proteins could further contribute to vascular dysfunction and the pathogenesis of hypertension 22, 23 . There is extensive evidence that thiols potentiate eNOS activity and alleviate oxidant stress 24, 25 . NOS uncoupling induces oxidant stress and has previously been shown to occur with depletion of L-Arg or BH 4 and 5 4) . b, Endothelium-dependent vasorelaxation in spontaneously hypertensive (SHR) and control (WKY) aortic rings. SHR rings showed a marked decrease in relaxation to acetylcholine; however, DTT (as above) re-established the acetylcholine response. Endothelium-independent relaxation (right) was similar for both SHR and WKY rings. Aortic relaxation is expressed as in a. P , 0.05, SHR versus WKY or SHR 1 DTT (n 5 4). See also Supplementary  Fig. 10 . c, eNOS S-glutathionylation of SHR and WKY aortae. Top: WKY and SHR aortae, either untreated or DTT-pretreated as in b, were homogenized. This was followed by immunoprecipitation with anti-eNOS antibody. The immunoprecipitation products were separated by SDS-PAGE followed by immunoblotting against anti-GSH and anti-eNOS antibodies. In SHR aortae, eNOS S-glutathionylation was markedly increased compared with WKY aortae and was abolished by pretreatment with DTT. Bottom: ratio of relative intensity of eNOS S-glutathionylation/eNOS, normalized to SHR aortae. There is only trace eNOS S-glutathionylation in WKY aortae, whereas high levels are seen in SHR aortae. There was no detectable (n.d.) NOS S-glutathionylation in DTTpretreated WKY or SHR aortae. Asterisk, P , 0.001 versus SHR (n 5 5).
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elevation of methylarginine levels 4, [26] [27] [28] . Here we show that eNOS possesses specific redox-sensitive thiols that are readily S-glutathionylated in endothelial cells and vessels with marked endothelial dysfunction and hypertension. This oxidative modification switches eNOS from its classical NO synthase function to that of an NADPH-dependent oxidase generating O 2 .2 , which occurs primarily from the reductase domain and, in contrast to other uncoupling mechanisms, is not inhibited by typical NOS inhibitors. Because NO and O 2 .2 have many opposing roles in cell signalling and vascular function 29 , S-glutathionylation of eNOS will trigger profound changes in cellular and vascular function and will mediate redox-signalling under oxidative stress. This mechanism of eNOS uncoupling could be triggered by other uncoupling processes such as BH 4 depletion, but could also further enhance BH 4 depletion. Further studies will be needed to elucidate these interactions.
These observations provide a new molecular understanding of how oxidant stress alters endothelial function and vascular tone and how the restoration or supplementation of reducing equivalents can restore endothelial function and normalize vascular tone. Therapeutics with thiol-reducing properties can therefore now be developed and refined as potent drugs for reversing endothelial dysfunction and ameliorating hypertension and other cardiovascular disease. Recently, hydrogen sulphide, a potent reducing agent, has been identified as a critical endogenous signalling molecule conferring potent cardiac protection in diseases with oxidant stress 30 ; however, its mechanism of action is unknown. Our present observations provide a mechanism by which it might confer protection.
S-Glutathionylation thus uncouples eNOS, switching it from NO to O 2 .2 generation. This process is induced by oxidant stress and is reversible. Two highly conserved cysteine residues at the interface between the FMN-binding and FAD-binding domains are S-glutathionylated, leading to uncoupling with O 2 .2 generation. Oxidant stress triggers eNOS S-glutathionylation in endothelial cells and intact vessels. Furthermore, S-glutathionylation is increased in hypertensive vessels, resulting in impaired endothelium-dependent vasodilation. In view of the central importance of NO and eNOS-mediated endothelial dysfunction in diseases including heart attack, stroke, diabetes and cancer, identification of this novel redox-signalling pathway provides new insights into therapeutic approaches for the prevention or amelioration of many of the most prevalent diseases afflicting mankind.
METHODS SUMMARY
heNOS was expressed, purified and characterized as described 15 . EPR spin-trapping and fluorescence were used to measure NO and O 2 .2 generation. Immunofluorescence microscopy and immunoprecipitation were applied to detect eNOS S-glutathionylation in BAECs and aortae. Specific cysteine residues of eNOS that are S-glutathionylated were identified by mass spectrometry, and site-directed mutagenesis was performed to determine their role in enzyme function in vitro and in vivo. Acetylcholine-dependent relaxation of aortic rings was used to determine endothelium-dependent vasodilator function.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
METHODS
heNOS purification. heNOS was purified from an Escherichia coli overexpression system in which plasmids expressing heNOS (pCWheNOS or pDEST17heNOS) and calmodulin (pCaM) were co-transformed into BL21(DE3). The detailed expression procedures have been described previously 15, 31 . Determination of protein and haem content. Protein concentration of purified heNOS was determined by the Bradford protein assay (Bio-Rad), with BSA as a standard. The haem content of heNOS was determined by pyridine haemochromogen assay. heNOS (50 mg) was added to a solution containing 0.15 M NaOH and 1.8 M pyridine, and the difference spectrum (reduced minus oxidized bispyridine haem) was recorded and quantified by using De 5 24 mM 21 cm 21 at 556-538 nm. Reduction of the bispyridine haem was achieved by the addition of a few grains of dithionite 15, 32 . Thiol modification of heNOS. To induce protein S-glutathionylation in vitro, purified heNOS was incubated for 20 min with the specified GSSG concentration in 50 mM Tris-HCl pH 7.4 at room temperature 33 . To alkylate all accessible thiols on heNOS, the purified heNOS was incubated for 20 min with 1 mM NEM in 50 mM Tris pH 7.4 at room temperature. Thiol modified enzyme preparations were then subjected to further analysis: immunoblotting, NO activity assay, and NO and O 2 .2 measurement 4, 15, 26, [34] [35] [36] [37] . For mass spectrometric identification of sites of S-glutathionylation, heNOS was incubated for 1 h with 2 mM GSSG at room temperature and then subjected to SDS-PAGE separation under non-reducing conditions. The molar ratio of eNOS to GSSG was 1:250 when 2 mM GSSG was used for the reaction. Measurement of NADPH consumption. NADPH oxidation 28 was followed spectrophotometrically at 340 nm with a Varian Cary 300 UV-Vis spectrophotometer. The reaction mixture (total volume 500 ml) contained 10 mg of CaM, 100 mM L-Arg, 200 mM NADPH, 10 mM BH 4 and 500 mM CaCl 2 in 50 mM TrisHCl pH 7.4. heNOS (2-5 mg) was used in the NADPH consumption assay. The reaction was initiated by the addition of 10 ml of 10 mM NADPH, and all experiments were run at room temperature. The rate of NADPH oxidation during the first 10 min was followed and the initial rate was calculated from the linear portion and an extinction coefficient of 6.22 mM 21 cm
21
.
Measurement of O 2
.2 generation by EPR spin trapping. Spin-trapping measurements of oxygen radical production from heNOS were performed in 50 mM Tris-HCl buffer pH 7.4 containing 0.5 mM NADPH, 0.5 mM Ca 21 , 10 mg ml 21 calmodulin, 15 mg ml 21 purified heNOS and 25 mM DEPMPO 15, 37 . For these measurements the binding of BH 4 to heNOS was reconstituted in advance by incubation of the enzyme with 100 mM BH 4 for 3 h; the unbound BH 4 was then removed to prevent superoxide scavenging. EPR spectra were recorded in a 50-ml capillary at room temperature with a Bruker EMX spectrometer operating at 9.86 GHz with 100 kHz modulation frequency at room temperature, as described 15 . Spectra were measured by using the following parameters: centre field 3,510 G; sweep width 140 G; power 20 mW; receiver gain 2 3 10 5 ; modulation amplitude 0.5 G; conversion time 41 ms; time constant 328 ms. SDS-PAGE and immunoblotting. The standard procedures for SDS-PAGE and immunoblotting were followed as described previously 15 . The reaction mixture was separated on a 4-20% Tris-glycine polyacrylamide gradient gel. Samples were run at room temperature for 1.5 h at 125 V. Protein bands were transferred electrophoretically to a nitrocellulose membrane in 12 mM Tris-HCl, 96 mM glycine, 20% methanol with an Xcell II Blot Module (Invitrogen) with 25 V constant for 90 min. Membranes were blocked for 1 h at room temperature in Tris-buffered saline (TBS) containing 0.05% Tween 20 (TTBS), with 5% dried milk (Bio-Rad). Membranes were then incubated overnight with anti-glutathione monoclonal antibody (ViroGen) or anti-eNOS polyclonal antibody (Santa Cruz) at 4 uC. Membranes were then washed three times in TTBS and incubated for 1 h with horseradish peroxidase-conjugated anti-mouse or anti-rabbit IgG in TTBS at room temperature. Membranes were again washed three times in TTBS and were then detected with ECL Western Blotting detection reagents (Amersham Biosciences). The signal intensity of blotting was digitized and quantified with ImageJ from the National Institutes of Health. Mass spectrometry. The protein sample was subjected to SDS-PAGE on a 4-20% gradient polyacrylamide gel. Protein bands on the gel were then stained with Coomassie blue. The band containing S-glutathionylation of heNOS, which was confirmed by immunoblotting against anti-GSH antibody, was cut and digested in-gel with trypsin, chymotrypsin, or trypsin and chymotrypsin before mass spectrometric measurement 33 . The S-glutathionylation of heNOS was determined with capillary-liquid chromatography tandem mass spectrometry (Nano-LC-MS/MS), which was performed on a LTQ or LTQ Orbitrap mass spectrometer (Thermo). The detailed parameters used in the MS measurements have been described in our previous study 33 . Sequence information from MS/MS data was processed with Mascot Distiller software, by using standard data processing parameters. Database searches were performed with the MASCOT (Matrix Science) program. Modelling. The three-dimensional structure of heNOS reductase domain was predicted by use of the Swiss-Model First Approach Mode 38 . The input sequence of heNOS starts from Ala 515 to Ser 1177 of heNOS. The lower Blast P(N) limit for template selection was set to 0.00001. The three-dimensional structure of the reductase domain of rat neuronal NOS (PDB ID 1F20) was also used as the self-input template file for the tertiary structure prediction of the heNOS reductase domain. The final model output was a Swiss-PDB viewer project file. PyMOL (DeLano Scientific LLC) was used to construct and view the three-dimensional structure of the heNOS reductase domain. Site-directed mutagenesis of heNOS. For bacterial expression, the human NOS3 gene was subcloned into pDEST17 vector (Invitrogen). It contains a His tag at the amino terminus of heNOS. The reading frame and heNOS sequence were confirmed by DNA sequencing. QuikChange site-directed mutagenesis (Stratagene) was used for heNOS CysRSer mutations. Primers for each mutation were as follows: Cys 689RSer, 59-GGCGACGAGCTGAGCGGCCAGGAGG-39 (sense) and 59-CCTCCTGGCCGCTCAGCTCGTCGCC-39 (antisense); Cys 908RSer, 59-GAAGTGGTTCCGCAGCCCCACGCTGC-39 (sense) and 59-GCAGCGTGG GGCTGCGGAACCACTTC-39 (antisense). The sequence of each heNOS mutant was further confirmed by DNA sequencing. The detailed procedures of protein expression and purification have been described previously 15, 31 . For mammalian expression, the human NOS3 gene was subcloned into pcDNA-DEST40 gateway vector (pc40heNOS) (Invitrogen). It contains the V5 epitope and a His tag at the carboxy terminus of heNOS. The reading frame and heNOS sequence were confirmed by DNA sequencing. QuikChange site-directed mutagenesis (Stratagene) was used for heNOS CysRAla mutations. Primers for each mutation were as follows: Cys 689RAla, 59-GGCGACGAGCTGGCCGGCCAG GAGG-39 (sense) and 59-CCTCCTGGCCGGCCAGCTCGTCGCC-39 (antisense); Cys 908RAla, 59-GAAGTGGTTCCGCGCCCCCACGCTGCTG-39 (sense) and 59-CAGCAGCGTGGGGGCGCGGAACCACTTC-39 (antisense). The sequence of the heNOS double mutant (C689A/C908A) from pc40heNOS was further confirmed by DNA sequencing. For mammalian expression, COS-7 was used for heNOS overexpression for cellular assays, because there is no eNOS in COS-7, as reported previously 39 . Fluorescence and immunofluorescence microscopy. BAECs cultured on 22-mm 2 sterile coverslips (Harvard Apparatus) in 35-mm sterile dishes at a density of 10 4 cells per dish were subjected to treatment with BCNU for 4 h. BCNU, an inhibitor of glutathione reductase, has been shown to alter cellular redox environment, leading to an increased GSSG/GSH ratio. The increase in oxidized GSH leads to increased cellular S-glutathiolation. At the end of the experiment, cells attached to coverslips were washed with PBS, fixed for 10 min with 3.7% paraformaldehyde and permeabilized for 5 min with 0.25% Triton X-100 in Tris-buffered saline containing 0.01% Tween 20 (TBST), washed three times, and then blocked for 30 min with 1% BSA in TBST. Permeabilization is required to provide access for the antibody to the antigen throughout the cell. Permeabilization and washing is also critical for the detection of protein-bound GSH adducts, because it clears the free GSH that would otherwise bind the antibody. For detection of S-glutathionylation and eNOS, the fixed and permeabilized cells were incubated at room temperature for 1 h with mouse anti-GSH and rabbit anti-eNOS primary antibodies at a dilution of 1:2,000 in TBST containing 1% BSA, followed by secondary anti-mouse Alexa fluor-568 and antirabbit Alexa fluor-488-conjugated antibody (1:1,000 dilution) for 1 h at room temperature. The coverslips with cells were then mounted on a glass slide with Fluoromount G mounting medium and viewed with a Olympus FluoView-1000 confocal microscope at 360 magnification, and data were captured digitally and analysed.
To . Nuclei were stained with blue-fluorescent DAPI (1 mM) for 10 min in the incubator. After incubation, cells were washed with PBS and mounted; images were captured and analysed at 360 magnification by confocal fluorescence microscopy, and overlaid with LSM software 15 . En face sections. After surgery the aortae from WKY and SHR rats were cleaned and washed with ice-cold PBS. A slit was made longitudinally and the opened aortae were fixed in 3.7% paraformaldehyde for 3 h at room temperature. The fixed aortae were washed for 2-3 h in 0.1 M cacodylate buffer and then incubated LETTER RESEARCH overnight with 2.3 M sucrose gradients titrated for 10 min each with 5% sucrose in cacodylate buffer (2:1, 1:1, 1:2 and 1:3) and 2.3 M sucrose at 4 uC. The samples were then mounted in OCT medium and frozen in liquid nitrogen 40 . Tissues were cryosectioned en face from anterior to posterior and the sections were probed for eNOS and PrS-SG. The sections were permeabilized with 0.25% Triton X-100 for 10 min and washed, followed by immunostaining for eNOS/PrS-SG as described above. High-magnification images were obtained and analysed with an Olympus FluoView-1000 confocal microscope at 3100 original magnification. EPR spin-trapping measurement of NO production. Spin-trapping measurements of NO from BAECs were performed with a Bruker EMX spectrometer with Fe-N-methyl-D-glucamine dithiocarbamate (Fe-MGD) as the spin trap 35, 36 . Spintrapping experiments were performed on cells grown in six-well plates (10 6 cells per well). Before EPR spin-trapping measurements, control cells or cells treated with BCNU were washed twice with PBS (without CaCl 2 or MgCl 2 ). Next, 0.8 ml of PBS containing glucose (1 g l 21 ), CaCl 2 , MgCl 2 , the NO spin-trap Fe-MGD (0.5 mM Fe 21 , 5.0 mM MGD) and calcium ionophore (1 mM) was added to each well, and the plates were incubated for 20 min at 37 uC in a humidified environment containing 5% CO 2 /95% O 2 . After incubation, the medium from each well was removed, and the trapped NO in the supernatants was quantified by EPR. Spectra recorded from these cellular preparations were obtained with the following parameters: microwave power 20 mW; modulation amplitude 4.0 G; modulation frequency 100 kHz. Aortic preparations and functional measurements. Aortae were excised from anaesthetized and heparinized rats, placed in ice-cold buffer, cleaned of loosely adhering fat and connective tissue and cut into rings 5 mm in length for measurements of vascular tone as described previously, with minor modification 41 . In brief, aortic rings were mounted horizontally and connected to an isometric force transducer in organ chambers (Multi Wire Myograph, Model 610M; DMT) filled with 5 ml of Krebs-Henseleit (K-H) buffer (37 uC, pH 7.4) consisting of 118 mM NaCl, 4.6 mM KCl, 1.2 mM CaCl 2 , 1.2 mM NaH 2 PO 4 , 24mM NaHCO 3 , 18 mM glucose, 10 mM indomethacin and 4.6 mM HEPES bubbled with 95% O 2 /5% CO 2 . The aortic segments were allowed to equilibrate for 60 min with an initial tension of 1 g. The stability of each ring was checked by the successive administration of 4 M KCl. Preparations were then washed three times with drugfree oxygenated K-H buffer and allowed to relax fully for 15 min before the experimental protocol began. Then the aortic rings were contracted with phenylephrine (10 mM) and, after stable contraction, the vasorelaxant effects of cumulative addition of acetylcholine, NONOate or sodium nitroprusside (SNP) were determined by measuring the tension and expressing this as the percentage relaxation with respect to the maximal phenylephrine contraction. To induce S-glutathionylation, rings were pretreated with 80 mM BCNU during the 60 min equilibration period, and to reverse S-glutathionylation the rings were treated with 1 mM DTT for 20 min. Similarly, to reverse the intrinsic S-glutathionylation present, SHR or WKY aortae or aortic rings were treated with 1 mM DTT for 20 min at 37 uC. For immunoprecipitation studies measuring the effect of DTT in reversing eNOS glutathionylation in aortae, DTT was added to the bioassay blood vessels, taking care to employ exactly the same conditions with the same duration of incubation and concentration of DTT as in the experiments measuring endothelial function. We then washed out the DTT and immunoprecipitated eNOS from the vessel homogenates.
For the BCNU studies, male Sprague-Dawley rats (Harlan) were used. Male SHR and WKY rats were supplied by Harlan or Charles River. NOS3 gene silencing in bovine aortic endothelial cells. NOS3 gene silencing from BAECs was used to confirm eNOS S-glutathionylation induced by BCNU contributing to increased cellular superoxide generation. The sequence of NOS3 siRNA was based on a previous study 42 
